USD
GBP 
CNY 
EUR 
INR 
JPY 
MYR 
ZAR 
KRW 
THB 
Innovative Fertility-as-a-Service Business Models and the Increase in IVF being Offered as an Employment Perk, and the Rise in Egg-freezing Cycles will Accelerate Growth in the Market
28-May-2019
North America
Market Research
ME90-01-00-00-00
HC03178-NA-MR_23234
Today, the journey of starting a family does not look the way it did fifty years ago, and people are turning to fertility services for help. 1 in 8 couples in the United States experience pregnancy-related difficulties that fertility treatments can address.
Key market drivers include the increasing rate of obesity causing deterred ovulation in women and low sperm quality in men; decreasing fertility of women due to physiological reasons; the preference to have children after the age of 35; and the rising number of single parents of choice and LGBTQ+ individuals or couples pursuing parenthood. In the United States, 8.1% of millennials identify as LGBTQ+ and need access to fertility coverage to build their families.
The US IVF market is fragmented and served by mostly small regional clinics. There are about 480 US fertility clinics, more than 100 sperm banks, and 1,700 reproductive endocrinologists competing in this lucrative business. Furthermore, ancillary services such as egg freezing, pre-implantation genetic testing (PGT), and surrogacy options are all leading to additional choices for patients and are driving additional market opportunity, in addition to the rise of fertility benefit companies.
Despite higher efficiency and clinical effectiveness, the high cost of IVF solutions has been one of the key market restraints, especially in the low and medium income segments. However, this is expected to change in the future, driven by new business models by the vendors, and the rise of fertility benefit companies and employers offering coverage for fertility treatment of employees.
Research Scope
The research service provides an overview of the US IVF Services Market and provides a 5-year forecast from 2018 to 2023. The total fertility market is segmented into assisted reproductive technology (ART) services and fertility medications. ART services comprise in vitro fertilization (IVF), Intracytoplasmic sperm injection (ICSI), gamete intrafallopian transfer (GIFT), and zygote intrafallopian transfer (ZIFT). IVF contributes 95% to 99% of total ART services. In this report, we have focused on the services supporting the IVF process.
Geographic scope of this study is the United States.
The study highlights key drivers and restraints in the market, regulatory and reimbursement landscape, current market dynamics, visioning scenarios, and key growth opportunities, such as Pre-implantation Genetic Testing (PGT), AI-based detection of viable embryos for IVF, Oocyte Cryopreservation/Elective Egg Freezing Services and Three-Parent IVF/Mitochondrial Replacement Therapy (MRT). Further the study includes a competitive landscape, in addition to key companies to watch, innovative business models/use cases in the market, and the strategic imperatives for the IVF services industry.
Key Issues Addressed
- How has the market attractiveness of IVF services grown over the years?
- What is the future market potential?
- Which are the disruptions that affect the value chain equilibrium?
- How new technology trends are impacting service providers?
- Which are the game-changing companies at work?
- What are the strategic levers that will help market participants to stay on the growth trajectory?
- What are the gaps in the market that provide opportunities to new entrants and encourage penetration?
- What are the latest IVF service business models?
- What should market participants do to stay competitive? What are the go-to-customer models and innovation in customer segmentation that the reader can expect?
Author: Saravanan Thangaraj
Key Findings
Market Scope and Segmentation
Key Questions Addressed in this Study
Big Market Themes
Role of IVF in ART Services
Market Snapshot
Success Rates of IVF Services in US
IVF Clinic Distribution Across US States
Regulatory Environment Analysis
Regulatory Environment Analysis (continued)
Reimbursement Scenario Analysis
Reimbursement Scenario Analysis (continued)
Impact of Femtech on Fertility Market
Key Market Drivers
Market Drivers Explained
Key Market Restraints
Market Restraints Explained
Fertility Benefit from Employers
Fertility Benefit from Employers (continued)
Fertility Benefit from Employers (continued)
Private Equity and VC Investments
Private Equity Investments in IVF Clinics
Entry Barriers for New Entrants in the US IVF Market
Revenue Forecast
Revenue Forecast Assumption
Revenue Forecast Assumption (continued)
Vendor Ecosystem
Market Share Analysis of Top 10 IVF Fertility Groups
Key Companies to Watch—Progyny, Inc.
Key Companies to Watch—Glow, Inc
Key Companies to Watch—Genomic Prediction
Key Companies to Watch—Life Whisperer
Mergers, Acquisitions, and Partnership Assessment
Egg Freezing as a Service with a Focus on Wellness
Egg Freezing as a Service with a Focus on Wellness (continued)
Accurate IVF Success Prediction Service Through Machine Learning
Use Case—Digital solutions for Patient Engagement in IVF Services
Visioning Scenarios for the US IVF Services Market
Visioning Scenarios for the US IVF Services Market (continued)
Visioning Scenarios for the US IVF Services Market (continued)
Major Growth Opportunities
Growth Opportunity 1—Preimplantation Genetic Testing (PGT)
Growth Opportunity 2—AI-based Detection of Viable Embryos for IVF
Growth Opportunity 3—Oocyte Cryopreservation/Elective Egg Freezing Services
Growth Opportunity 4—Three-Parent IVF or Mitochondrial Replacement Therapy (MRT)
Growth Opportunity Matrix
Calls to Action for IVF Service Providers
Key Success Factors for IVF Clinics
3 Big Predictions
Legal Disclaimer
Major Causes of Infertility in the United States
List of Exhibits
The Frost & Sullivan Story
Value Proposition—Future of Your Company & Career
Global Perspective
Industry Convergence
360º Research Perspective
Implementation Excellence
Our Blue Ocean Strategy
Speak directly with our analytics experts for tailored recommendations.
Recent related Life Sciences research
13 Jan 2025 | Global | Market Outlook
Top 6 Growth Opportunities for the Digital Health Industry, 2025
Driven by digital advancements, the healthcare industry is transforming rapidly. Current trends and challenges create constant change, and industry stakeholders must adapt to remain attractive, competitive, and unique as robust organizations. Each year, competitors must gain a fresh, comprehensive v...
17 Dec 2024 | Global | Market Research
Cybersecurity in Healthcare, United States, 2024
Healthcare is the industry most affected by cyberattacks, which have targets like hospitals, healthcare organizations, patient databases, and connected devices. These attacks not only destabilize healthcare systems but also threaten care delivery and patient safety. The global healthcare infrastruct...
12 Dec 2024 | Global | Market Outlook
Top 6 Growth Opportunities for Clinical Diagnostics, Global, 2025
Accounting for 2%-3% of total healthcare expenditure and influencing 70% of clinical decision-making, diagnostics is the silent champion supporting all stages of precision health, including risk stratification, screening, early diagnosis, prognosis, monitoring, and relapse. The discovery and trans...
05 Dec 2024 | Global | Frost Radar
Frost Radar™: Enterprise Conversational AI in Healthcare, 2024
This Frost Radar™ benchmarks the companies and their solutions that allow healthcare payers and providers to create next-generation virtual assistants. Conversational AI is primarily used to streamline patient and provider processes and interactions across the care continuum—the pre-care, at-care, a...
27 Nov 2024 | Global | Market Research
Generative AI in Payer and Provider IT Transformation, Global, 2024-2029
The healthcare payer and provider industry is gradually adopting generative artificial intelligence (Gen AI) solutions across its value chain. Almost all organizations have shown an intent to implement Gen AI-based solutions in their products or processes, with a few already embarking on this journe...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
Research Scope
The research service provides an overview of the US IVF Services Market and provides a 5-year forecast from 2018 to 2023. The total fertility market is segmented into assisted reproductive technology (ART) services and fertility medications. ART services comprise in vitro fertilization (IVF), Intracytoplasmic sperm injection (ICSI), gamete intrafallopian transfer (GIFT), and zygote intrafallopian transfer (ZIFT). IVF contributes 95% to 99% of total ART services. In this report, we have focused on the services supporting the IVF process.
Geographic scope of this study is the United States.
The study highlights key drivers and restraints in the market, regulatory and reimbursement landscape, current market dynamics, visioning scenarios, and key growth opportunities, such as Pre-implantation Genetic Testing (PGT), AI-based detection of viable embryos for IVF, Oocyte Cryopreservation/Elective Egg Freezing Services and Three-Parent IVF/Mitochondrial Replacement Therapy (MRT). Further the study includes a competitive landscape, in addition to key companies to watch, innovative business models/use cases in the market, and the strategic imperatives for the IVF services industry.
Key Issues Addressed
- How has the market attractiveness of IVF services grown over the years?
- What is the future market potential?
- Which are the disruptions that affect the value chain equilibrium?
- How new technology trends are impacting service providers?
- Which are the game-changing companies at work?
- What are the strategic levers that will help market participants to stay on the growth trajectory?
- What are the gaps in the market that provide opportunities to new entrants and encourage penetration?
- What are the latest IVF service business models?
- What should market participants do to stay competitive? What are the go-to-customer models and innovation in customer segmentation that the reader can expect?
Author: Saravanan Thangaraj
| Deliverable Type | Market Research |
|---|---|
| No Index | No |
| Podcast | No |
| Author | Saravanan Thangaraj |
| Industries | Healthcare |
| WIP Number | ME90-01-00-00-00 |
| Is Prebook | No |
| GPS Codes | 9564-B1,9600-B1,9612-B1,9562-B1,9A47-B1,9A4B-B1,9627-B1 |
Growth Insights on the US In vitro Fertilization Services Market, 2018
$3,000.00
Special Price $2,250.00 save 25 %